Maduck Sean
Maduck Sean, SR, reported a transaction classified as exercise at CORCEPT THERAPEUTICS INC involving 75000.000000 shares for an estimated $620250.00. Reported holdings after the transaction were 83977.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- May 27, 2026
- Filing date
- May 29, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CORT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-248967 Common Stock
- Transaction date
- May 27, 2026 Filed May 29, 2026, 10:03 PM · 2d delay
- Shares
- 75,000 sh $8.27 per share
- Estimated value
- $620k Computed from shares × price
- Holdings after
- 83,977 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
See Remarks
- F1
Includes 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 shares underlying unvested restricted stock awards granted to the Rep…
- F2
This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $65.00 to $65.99 per share. Information on the exact number of shares sold at each sa…
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $66.00 to $66.50 per share. Information on the exact number of shares sold at each sa…
- F5
Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee.
- F6
Represents the shares held by MMM 2025, LLC of which the Reporting Person is a member and manager.
- F7
Represents the shares held by SNM 2025 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.
- F8
Represents the shares held by SNM 2026 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.
- F9
Represents the shares held by Duckhill Capital, LLC of which the Reporting Person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- F10
Fully exercisable.
0 other transactions
0 recent txs